Jump to content

NSCLC with MET Clinical Trial


Recommended Posts

NSCLC with MET Clinical Trial

“You may qualify for a new clinical trial specific to your type of lung cancer. Massive Bio is working with a Pharmaceutical Sponsor to identify and determine eligibility of patients with MET-Altered Advanced Non-Small Cell Lung Cancer (NSCLC) to a novel drug in Phase 2 clinical trial. 

If you are interested in learning about this trial, please contact:
Kristin Johnston, BSN, RN, 
Chief Nursing Officer, Massive Bio, Inc. 
Phone: 267-918-3790
Email: kjohnston@massivebio.com “

Link to comment
Share on other sites


This topic is now archived and is closed to further replies.

  • Create New...

Important Information

By using this site, you agree to our Terms of Use. We have placed cookies on your device to help make this website better. You can adjust your cookie settings, otherwise we'll assume you're okay to continue.